Johnson & Johnson Vaccine Pause
The CDC and FDA recommended temporarily pausing further administration of the Johnson and Johnson vaccine out of an abundance of extreme caution. While no Minnesota vaccination sites are using J&J this week, but there will still be temporarily pause in the use of J&J at this time. Out of the 7 million who have received the Johnson & Johnson vaccine, 6 people experienced a rare and severe type of blood clot after getting their shot. These 6 people were all women between the ages of 18 and 48 and had symptoms present 6-13 days after the vaccination. One woman in Virginia passed away, and a second woman in Nebraska is hospitalized in critical condition. The CDC’s Advisory Committee on Immunization Practices (ACIP) will meet Wednesday to further review these cases. These cases are extremely rare, but caution is still being taken to further secure the safety of everyone. Anyone who has received the J&J vaccine who develops severe headache, abdominal pain, leg pain, or shortness of breath within a few weeks should contact their doctor.